Bioequivalence Study of TNX-102 SL 2.8 mg Sublingual Tablets From Two Manufacturers. (Q66043663)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bioequivalence Study of TNX-102 SL 2.8 mg Sublingual Tablets From Two Manufacturers. |
clinical trial |
Statements
A SINGLE-DOSE, RANDOMIZED, OPEN-LABEL, TWO-WAY CROSSOVER BIOEQUIVALENCE STUDY OF TNX-102 SL (CYCLOBENZAPRINE HCL SUBLINGUAL TABLETS) 2.8 mg FROM TWO MANUFACTURERS IN HEALTHY SUBJECTS UNDER FASTING CONDITIONS (English)
0 references
16 December 2015
0 references
26 January 2016
0 references
43
0 references
18 year
0 references
65 year
0 references